Clicky

Ion Beam Applications SA(IOBCF)

Description: Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.


Keywords: Cancer Medical Imaging Treatment Of Cancer Radiation Medical Physics Physics Radiation Therapy Tomography Turnkey Solutions Radiobiology Nuclear Physics Radioactivity Proton Therapy Radiation Protection Accelerator Physics Particle Accelerator Fabricates Ion Beam Applications Medical Imaging Quality Assurance Proton Therapy Systems

Home Page: www.iba-worldwide.com

3, Chemin du Cyclotron
Louvain-la-Neuve, 1348
Belgium
Phone: 32 1 047 58 11


Officers

Name Title
Mr. Pierre Mottet Chairman of The Board
Mr. Olivier Legrain CEO, MD & Executive Director
Mr. Yves Jongen Founder, Chief Research Officer, MD & Executive Director
Ms. Soumya Chandramouli Chief Financial Officer
Marc Van der Burght Chief Operation Officer
Olivier Lechien Corporate Communication Director
Thomas Canon Sustainability Program Director
Henri de Romree Deputy CEO
Bruno Scutnaire President of IBA RadioPharma Solutions

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 12.9032
Trailing PE: 51.6429
Price-to-Book MRQ: 4.464
Price-to-Sales TTM: 0.9062
IPO Date:
Fiscal Year End: December
Full Time Employees: 1943
Back to stocks